Address
Email address
Phone number
Website
https://www.bioplanet.eeToidulisandid, mis päriselt aitavad - Bioplanet OÜKvaliteetsed toidulisandid. Nordaid Eesti e-pood. Lisaks toome maale ja müüme e-poes ka teisi kõrgeima imendumisega vitamiine ja mineraale.
Name
OÜ Bioplanet
Registry code
11920653
VAT number
EE101392345
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
06.04.2010 (14)
Financial year
01.01-31.12
Capital
2 684.00 €
Activity
46461 - Wholesale of medicines and other pharmacy goods
753 268 €
1 952 €
0%
746 €
(estimate is approximate)
178 899 €
1
Submitted
No tax arrears
1%
1%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Kalle Kõre 15.03.1970 (54) | 100% - 2 684.00 EUR | Board member | Direct ownership | |
| Marit Kõre 03.06.1985 (39) | - | Board member | - |
| 2019 05.08.2020 | 2020 24.06.2021 | 2021 01.06.2022 | 2022 01.06.2023 | 2023 29.05.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 491 667 € | 747 813 € | 865 466 € | 828 486 € | 753 268 € |
| Net profit (loss) for the period | 23 188 € | 98 762 € | 2 689 € | 3 681 € | 1 952 € |
| Profit Margin | 5% | 13% | 0% | 0% | 0% |
| Current Assets | 258 543 € | 373 230 € | 294 982 € | 345 493 € | 262 123 € |
| Fixed Assets | 74 781 € | 59 762 € | 58 119 € | 51 426 € | 36 649 € |
| Total Assets | 333 324 € | 432 992 € | 353 101 € | 396 919 € | 298 772 € |
| Current Liabilities | 211 509 € | 212 415 € | 179 835 € | 219 972 € | 119 873 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 121 815 € | 220 577 € | 173 266 € | 176 947 € | 178 899 € |
| Employees | 1 | 1 | 1 | 1 | 1 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 252 099.28 € | 12 287.8 € | 1 286.64 € | 1 |
| 2023 Q4 | 302 493.93 € | 18 091.32 € | 1 232.79 € | 1 |
| 2023 Q3 | 194 766.63 € | 13 468.8 € | 1 565.76 € | 1 |
| 2023 Q2 | 195 246.12 € | 12 938.32 € | 1 232.79 € | 1 |
| 2023 Q1 | 298 941.37 € | 19 556.37 € | 1 075.21 € | 1 |
| 2022 Q4 | 307 203.04 € | 11 587.48 € | 961.77 € | 1 |
| 2022 Q3 | 202 875.43 € | 9 138.86 € | 961.77 € | 1 |
| 2022 Q2 | 178 775.03 € | 12 297.53 € | 961.77 € | 1 |
| 2022 Q1 | 307 014.18 € | 25 737.69 € | 2 261.44 € | 1 |
| 2021 Q4 | 391 164.43 € | 26 264.87 € | 961.77 € | 1 |
| 2021 Q3 | 175 563.72 € | 7 138.21 € | 961.77 € | 1 |
| 2021 Q2 | 209 863.25 € | 10 492.32 € | 984.87 € | 1 |
| 2021 Q1 | 330 957.62 € | 17 683.05 € | 947.25 € | 1 |
| 2020 Q4 | 306 061.89 € | 19 444.85 € | 918.21 € | 1 |
| 2020 Q3 | 146 979.61 € | 13 087.14 € | 1 618.21 € | 1 |
| 2020 Q2 | 204 838.69 € | 15 695.17 € | 1 108.33 € | 1 |
| 2020 Q1 | 231 431.37 € | 17 457.5 € | 918.21 € | 1 |
